0 CHECKOUT

PRODUCT FILTERS

REGION

29
23
22
16
16

COUNTRY

16
7
6
6
6

PRICE

2
40
71
143

PUBLISHED

43
48
85
143

PRODUCT TYPE

143

Brain Cancer

With low survival rates primary brain cancers such as glioblastoma multiforme (the most common and aggressive of malignant brain tumours) are among the deadliest forms of cancer. Drug development activity is therefore intense in this sector, with resulting business development opportunities. Reports in the Brain Cancer section enable you to explore various facets of the industry from a variety of expert viewpoints, including R&D (clinical trials, drug discovery, etc.), competitive landscape, supply and demand, regional markets, regional market analysis, and much more. Show Less Read more

Glioblastoma Multiforme Treatment (GBM) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

Glioblastoma multiforme (GBM) is the most frequent and lethal primary brain tumor in adults. The current treatment modalities available in the market are surgical resection followed by chemotherapy...

Published:  June 2015
Price:  From

Global Glioblastoma Multiforme Therapeutics Market 2015-2019

About Glioblastoma Multiforme Glioblastoma multiforme is the most aggressive variant of malignant brain cancer. It has a poor prognosis with low rate of survival, a median of one year. The primary brain...

Published:  July 2015
Price:  From

Brain Cancer (Glioblastoma Multiforme): Disease and Pipeline Analysis

This report offers a unique therapeutic assessment and in-depth market and pipeline analysis, providing a view of the glioblastoma multiforme (brain cancer) market not available elsewhere. This reports...

Published:  January 2014
Price:  From

CAS Cyclophosphamide World Consumption Report

This CAS Cyclophosphamide World Consumption Report provides data on the net consumption of CAS 50-18-0 - Cyclophosphamide Substance(s) in each of the countries listed. The Substance(s) covered (Cyclophosphamide...

Published:  February 2016
Price: 

CAS Methotrexate World Consumption Report

This CAS Methotrexate World Consumption Report provides data on the net consumption of CAS 59-05-2 - Methotrexate Substance(s) in each of the countries listed. The Substance(s) covered (Methotrexate...

Published:  February 2016
Price: 

Metastatic Brain Tumor-API Insights

Summary Metastatic Brain Tumor-API Insights, 2015 report provides Metastatic Brain Tumor drugs marketed details and API Manufacturers details across the globe along with the location. The report...

Published:  February 2016
Price:  From

Metastatic Brain Tumor-Pipeline Insights

Summary Metastatic Brain Tumor- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Metastatic Brain Tumor. The main objective of this report to track competitor pipeline...

Published:  February 2016
Price:  From

Recurrent Malignant Glioma -Pipeline Insights

Summary Recurrent Malignant Glioma - Pipeline Insights provides the in-depth analysis of the pipeline assets across the Recurrent Malignant Glioma . The main objective of this report to track competitor...

Published:  February 2016
Price:  From

Malignant Glioma-API Insights

Summary Malignant Glioma-API Insights, 2015 report provides Malignant Glioma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear...

Published:  February 2016
Price:  From

Astrocytoma-Pipeline Insights

Summary Astrocytoma- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Astrocytoma. The main objective of this report to track competitor pipeline molecules, related...

Published:  February 2016
Price:  From

Zortress-API Insights

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large...

Published:  February 2016
Price:  From

Recurrent Malignant Glioma -Pipeline Insights, 2016

“ Recurrent Malignant Glioma -Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Recurrent Malignant Glioma . The report covers the...

Published:  February 2016
Price:  From

Recurrent Malignant Glioma-Pipeline Insights, 2016

“ Recurrent Malignant Glioma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Recurrent Malignant Glioma. The report covers the...

Published:  February 2016
Price:  From

Medulloblastoma-Pipeline Insights, 2016

“ Medulloblastoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Medulloblastoma. The report covers the product profiles in various...

Published:  February 2016
Price:  From

Metastatic Brain Tumor-Pipeline Insights, 2016

“ Metastatic Brain Tumor-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Metastatic Brain Tumor. The report covers the product...

Published:  February 2016
Price:  From

Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  February 2016
Price:  From

Gliosarcoma-Pipeline Insights, 2016

“ Gliosarcoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Gliosarcoma. The report covers the product profiles in various stages...

Published:  February 2016
Price:  From

Astrocytoma-Pipeline Insights, 2016

“ Astrocytoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Astrocytoma. The report covers the product profiles in various stages...

Published:  February 2016
Price:  From

Anaplastic Astrocytoma-Pipeline Insights, 2016

“ Anaplastic Astrocytoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Anaplastic Astrocytoma. The report covers the product...

Published:  February 2016
Price:  From

Oligodendroglioma-Pipeline Insights, 2016

“ Oligodendroglioma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Oligodendroglioma. The report covers the product profiles...

Published:  February 2016
Price:  From
Loading Indicator

Our Clients